← Eichor
Condition: Follicular Lymphoma Grade 3 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Follicular Lymphoma Grade 3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
Phase 2 · 1 location(s) · Evopoint Biosciences Inc. · NCT07545603A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Remission in Adults With Severe Asthma in Thailand
Phase N/A · 1 location(s) · Thammasat University · NCT07328035Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy
Phase N/A · 4 location(s) · Mount Sinai Hospital, Canada · NCT05708105Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatat
NA · 1 location(s) · Istituto Oncologico Veneto IRCCS · NCT06941194Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher V
Phase N/A · 2 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT05319067Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Phase 2 · 1 location(s) · Mayo Clinic · NCT04082520A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Phase 1 · 4 location(s) · AstraZeneca · NCT07546760Novel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant Volume
Phase N/A · 1 location(s) · Germans Trias i Pujol Hospital · NCT07528781Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT07468136Prone Positioning in ARDS: Predicting Neurological Complications Via Cerebral Hemodynamics
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT06967285Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07256015Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progress
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06815029Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
NA · 1 location(s) · Shanghai 6th People's Hospital · NCT06241482Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment
Phase 1 · 8 location(s) · Novartis Pharmaceuticals · NCT07422610Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
Phase 2 · 27 location(s) · National Cancer Institute (NCI) · NCT05859334Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · 43 location(s) · National Cancer Institute (NCI) · NCT06860594Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06964737Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
NA · 2 location(s) · Rutgers, The State University of New Jersey · NCT06797219Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Phase 2 · 2 location(s) · Hope Biosciences LLC · NCT05951777Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Phase 1 · 1 location(s) · Northwestern University · NCT06410248Ovarian Hyperstimulation Syndrome Prevention
NA · 2 location(s) · Aljazeera Hospital · NCT06739759SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Phase 3 · 57 location(s) · Nuvation Bio Inc. · NCT05303519Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Phase 1/Phase 2 · 34 location(s) · Lyell Immunopharma, Inc. · NCT05826535STimulation to Activate RespIration
NA · 7 location(s) · Lungpacer Medical Inc. · NCT06832306Swedish Cardiac And Renal Failure Study-1
Phase 2 · 1 location(s) · Karolinska Institutet · NCT070295033'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
Phase N/A · 1 location(s) · Children's Hospital of Philadelphia · NCT06475976SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Dif
Phase 1 · 1 location(s) · Peter Hosein, MD · NCT06889493
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.